Physician

Laura Kathleen Altom, M.D.

According to 2025 Medicare claims, Laura Altom, M.D. (NPI: 1144481409) practices colorectal surgery (formerly proctology) in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is REX HOSPITAL INC (NPI: 1912338054; TIN: 561509260) and primary practice location at 27607-7505. Altom is affiliated with the CHESS Genesis, LLC (ACO ID: D0237), participating under the REACH model.

Altom's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 224 traditional Medicare patients, billed 477 HCPCS/CPT codes, and received $84,501 in Medicare payments. The top billing code was 46221 (Removal of external hemorrhoids by rubber banding). Part D data shows 253 prescription claims across 110 beneficiaries totaling $9,585 in drug costs, led by Neomycin Sulfate (Neomycin Sulfate). DME data shows 14 claims. Open Payments data shows 8 records totaling $151. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $23,379 and ending at $84,501. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,853 and ending at $9,585. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $176 to $197.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	48	109	$23,379
2017	157	419	$91,439
2018	226	554	$112,337
2019	244	605	$123,446
2020	167	388	$70,863
2021	181	455	$93,229
2022	214	500	$91,680
2023	205	443	$74,616
2024	224	477	$84,501

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	34	58	$2,853
2016	44	94	$1,170
2017	74	159	$3,847
2018	120	282	$15,751
2019	132	322	$8,882
2020	92	261	$9,068
2021	90	238	$12,097
2022	98	231	$4,257
2023	101	204	$5,189
2024	110	253	$9,585

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	99	$7,262
2019	12	222	$15,617
2020	11	170	$14,135
2021	N/R	146	$15,324
2022	N/R	43	$4,568
2023	N/R	99	$11,948
2024	N/R	14	$2,071

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
46221	Removal of external hemorrhoids by rubber banding	46	52	$193
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	19	19	$147
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	52	52	$111
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	63	100	$59
91120	Test for tone and sensation of rectum and anus	18	18	$36

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Neomycin Sulfate	Neomycin Sulfate	42	54	$211
Hydrocortisone	Hydrocortisone	15	307	$181
Metronidazole	Metronidazole	44	94	$100
Ondansetron Hcl	Ondansetron Hcl	29	39	$43
Oxycodone Hcl	Oxycodone Hcl	11	45	$18

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4385	Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each	N	N/R	14	$2,071

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$151	Ethicon US, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Laura Kathleen Altom, M.D.?

Tedicare shows public-source Medicare data for Laura Kathleen Altom, M.D. (NPI 1144481409), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Laura Kathleen Altom, M.D. have ACO affiliation data?

Laura Kathleen Altom, M.D. is shown with ACO affiliation data for CHESS Genesis, LLC (REACH, ACO ID D0237).

What billing organization is linked to Laura Kathleen Altom, M.D.?

Laura Kathleen Altom, M.D. is linked to REX HOSPITAL INC (billing NPI 1912338054) in the available physician profile data.

Does Laura Kathleen Altom, M.D. have Open Payments data?

Laura Kathleen Altom, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.